Across TCGA pan-cancer cohorts, OR5AZ1P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR5AZ1P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR5AZ1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR5AZ1P is over-expressed in tumor.
KIRC are the cancer types where OR5AZ1P tumor–normal differential expression is most reproducible.